Immunostaining of the NSCLC tumor samples with anti-CD31 antibody showed that the Meflin-high group tumors had greater tumor vessel area than the Meflin-low group (Fig 5B). The gene discussed is PECAM1; the disease is non-small cell lung carcinoma.